715 related articles for article (PubMed ID: 22168435)
21. QT-interval effects of methadone, levomethadyl, and buprenorphine in a randomized trial.
Wedam EF; Bigelow GE; Johnson RE; Nuzzo PA; Haigney MC
Arch Intern Med; 2007 Dec; 167(22):2469-75. PubMed ID: 18071169
[TBL] [Abstract][Full Text] [Related]
22. Methadone-associated QT interval prolongation in patients undergoing maintenance therapy in an urban opioid treatment program.
Titus-Lay EN; Jaynes HA; Tomaselli Muensterman E; Walroth TA; Ott CA; Desta Z; Williams G; Moe PR; Wilbrandt M; Tisdale JE
Pharmacotherapy; 2021 Mar; 41(3):238-246. PubMed ID: 33345336
[TBL] [Abstract][Full Text] [Related]
23. Methadone Therapy in Underserved Urban Community: QTc Prolongation and Life-Threatening Ventricular Arrhythmias.
Chowdhury M; Wong J; Cheng A; Khilkin M; Palma E
Cardiovasc Ther; 2015 Jun; 33(3):127-33. PubMed ID: 25825202
[TBL] [Abstract][Full Text] [Related]
24. QTc prolongation and torsades de pointes associated with methadone therapy.
Routhier DD; Katz KD; Brooks DE
J Emerg Med; 2007 Apr; 32(3):275-8. PubMed ID: 17394991
[TBL] [Abstract][Full Text] [Related]
25. QTc abnormalities in deliberate self-poisoning with moclobemide.
Downes MA; Whyte IM; Isbister GK
Intern Med J; 2005 Jul; 35(7):388-91. PubMed ID: 15958107
[TBL] [Abstract][Full Text] [Related]
26. Electrocardiographic abnormalities in opiate addicts.
Wallner C; Stöllberger C; Hlavin A; Finsterer J; Hager I; Hermann P
Addiction; 2008 Dec; 103(12):1987-93. PubMed ID: 19469742
[TBL] [Abstract][Full Text] [Related]
27. Literature review and pilot studies of the effect of QT correction formulas on reported beta2-agonist-induced QTc prolongation.
Milic M; Bao X; Rizos D; Liu F; Ziegler MG
Clin Ther; 2006 Apr; 28(4):582-90. PubMed ID: 16750469
[TBL] [Abstract][Full Text] [Related]
28. Prolonged QT interval by methadone: relevance for daily practice? A prospective study in patients with cancer and noncancer pain.
van den Beuken-van Everdingen MH; Geurts JW; Patijn J
J Opioid Manag; 2013; 9(4):263-7. PubMed ID: 24353019
[TBL] [Abstract][Full Text] [Related]
29. Accuracy of a single-lead mobile smartphone electrocardiogram for QT interval measurement in patients undergoing maintenance methadone therapy.
Titus-Lay EN; Jaynes HA; Tomaselli Muensterman E; Ott CA; Walroth TA; Williams G; Moe PR; Wilbrandt M; Tisdale JE
Pharmacotherapy; 2021 Jun; 41(6):494-500. PubMed ID: 33772822
[TBL] [Abstract][Full Text] [Related]
30. Sample size, power calculations, and their implications for the cost of thorough studies of drug induced QT interval prolongation.
Malik M; Hnatkova K; Batchvarov V; Gang Y; Smetana P; Camm AJ
Pacing Clin Electrophysiol; 2004 Dec; 27(12):1659-69. PubMed ID: 15613131
[TBL] [Abstract][Full Text] [Related]
31. The QTc effect of low-dose methadone for chronic pain: a prospective pilot study.
Grodofsky S; Edson E; Huang S; Speck RM; Hatchimonji J; Lacy K; Farrar JT; Ashburn MA
Pain Med; 2015 Jun; 16(6):1112-21. PubMed ID: 25644980
[TBL] [Abstract][Full Text] [Related]
32. Heterogeneous impact of methadone on the QTc interval: what are the practical implications?
Krantz MJ
J Addict Dis; 2008; 27(4):5-9. PubMed ID: 19042586
[TBL] [Abstract][Full Text] [Related]
33. Depression in methadone maintenance treatment patients: rate and risk factors.
Peles E; Schreiber S; Naumovsky Y; Adelson M
J Affect Disord; 2007 Apr; 99(1-3):213-20. PubMed ID: 17055063
[TBL] [Abstract][Full Text] [Related]
34. Effect of amphetamine on corrected-QT interval change during methadone maintenance treatment in Taiwan: a prospective cohort study.
Lin NC; Huang CL; Chen CY; Lin TY; Wang HY; Lu YH; Chen LM; Chen VC; Gossop M
Drug Alcohol Rev; 2014 Mar; 33(2):194-201. PubMed ID: 24320220
[TBL] [Abstract][Full Text] [Related]
35. Dose-related effects of methadone on QT prolongation in a series of patients with torsade de pointes.
Krantz MJ; Kutinsky IB; Robertson AD; Mehler PS
Pharmacotherapy; 2003 Jun; 23(6):802-5. PubMed ID: 12820821
[TBL] [Abstract][Full Text] [Related]
36. QTc prolongation among hospitalized patients receiving methadone.
Schmittner J; Krantz MJ
Arch Intern Med; 2006 Nov; 166(20):2289; author reply 2289-90. PubMed ID: 17101954
[No Abstract] [Full Text] [Related]
37. Measurement of QTc in patients receiving chronic methadone therapy.
Cruciani RA; Sekine R; Homel P; Lussier D; Yap Y; Suzuki Y; Schweitzer P; Yancovitz SR; Lapin JA; Shaiova L; Sheu RG; Portenoy RK
J Pain Symptom Manage; 2005 Apr; 29(4):385-91. PubMed ID: 15857742
[TBL] [Abstract][Full Text] [Related]
38. Effects of methadone on QT-interval dispersion.
Krantz MJ; Lowery CM; Martell BA; Gourevitch MN; Arnsten JH
Pharmacotherapy; 2005 Nov; 25(11):1523-9. PubMed ID: 16232014
[TBL] [Abstract][Full Text] [Related]
39. Assessing cardiac safety among clients receiving methadone as part of opioid agonist maintenance therapy (OAMT) in Durban, South Africa.
Prakaschandra DR; Scheibe A; Marks M; Naidoo DP
J Addict Dis; 2023; 41(1):82-90. PubMed ID: 35437125
[TBL] [Abstract][Full Text] [Related]
40. Electrocardiogram characteristics of methadone and buprenorphine maintained subjects.
Athanasos P; Farquharson AL; Compton P; Psaltis P; Hay J
J Addict Dis; 2008; 27(3):31-5. PubMed ID: 18956527
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
